Genmab: Epkinly Shines In Phase 3 DLBCL Trial

🇺🇸 Seeking Alpha (US) —

AI Summary

Genmab's Epkinly showed positive results in a Phase 3 trial for diffuse large B-cell lymphoma (DLBCL), according to the headline. The item offers no further details on trial outcomes or regulatory plans.

Markets Health Genmab Epkinly DLBCL Phase 3 clinical trial lymphoma treatment

Read original source →